Fadi Abdel-Sater, R. Makki, Alia Khalil, Nader Hussein, Nada Borghol, Ziad Abi Khattar, Aline Hamade, Nathalie Khreich, Mahoumd El Homsi, Hussein Kanaan, Line Raad, Najwa Skafi, Fatima Al-Nemer, Zeinab Ghandour, Nabil El-zein, Mohamad Abou-Hamdan, H. Akl, E. Hamade, B. Badran, K. Hamze
{"title":"利用基于 SYBR 绿的 RT-qPCR 检测 SARS-CoV-2 B.1.1.529 (omicron) 变异体","authors":"Fadi Abdel-Sater, R. Makki, Alia Khalil, Nader Hussein, Nada Borghol, Ziad Abi Khattar, Aline Hamade, Nathalie Khreich, Mahoumd El Homsi, Hussein Kanaan, Line Raad, Najwa Skafi, Fatima Al-Nemer, Zeinab Ghandour, Nabil El-zein, Mohamad Abou-Hamdan, H. Akl, E. Hamade, B. Badran, K. Hamze","doi":"10.1093/biomethods/bpae020","DOIUrl":null,"url":null,"abstract":"\n The COVID-19 pandemic is unceasingly spreading across the globe, and recently a highly transmissible Omicron SARS-CoV-2 variant (B.1.1.529) has been discovered in South Africa and Botswana. Rapid identification of this variant is essential for pandemic assessment and containment. However, variant identification is mainly being performed using expensive and time-consuming genomic sequencing. In this study we propose an alternative RT-qPCR approach for the detection of the Omicron BA.1 variant using a low-cost and rapid SYBR Green method. We have designed specific primers to confirm the deletion mutations in the spike (S Δ143-145) and the nucleocapsid (N Δ31-33) which are characteristics of this variant. For the evaluation, we used 120 clinical samples from patients with PCR-confirmed SARS-CoV-2 infections, and displaying an S-gene target failure (SGTF) when using TaqPath COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. Our results showed that all the 120 samples harbored S Δ143-145 and N Δ31-33, which was further confirmed by Whole genome sequencing (WGS) of ten samples thereby validating our SYBR Green-based protocol. This protocol can be easily implemented to rapidly confirm the diagnosis of the Omicron BA.1 variant in COVID-19 patients and prevent its spread among populations, especially in countries with high prevalence of SGTF profile.","PeriodicalId":36528,"journal":{"name":"Biology Methods and Protocols","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Detection of SARS-CoV-2 B.1.1.529 (omicron) variant by SYBR green‑based RT‑qPCR\",\"authors\":\"Fadi Abdel-Sater, R. Makki, Alia Khalil, Nader Hussein, Nada Borghol, Ziad Abi Khattar, Aline Hamade, Nathalie Khreich, Mahoumd El Homsi, Hussein Kanaan, Line Raad, Najwa Skafi, Fatima Al-Nemer, Zeinab Ghandour, Nabil El-zein, Mohamad Abou-Hamdan, H. Akl, E. Hamade, B. Badran, K. Hamze\",\"doi\":\"10.1093/biomethods/bpae020\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n The COVID-19 pandemic is unceasingly spreading across the globe, and recently a highly transmissible Omicron SARS-CoV-2 variant (B.1.1.529) has been discovered in South Africa and Botswana. Rapid identification of this variant is essential for pandemic assessment and containment. However, variant identification is mainly being performed using expensive and time-consuming genomic sequencing. In this study we propose an alternative RT-qPCR approach for the detection of the Omicron BA.1 variant using a low-cost and rapid SYBR Green method. We have designed specific primers to confirm the deletion mutations in the spike (S Δ143-145) and the nucleocapsid (N Δ31-33) which are characteristics of this variant. For the evaluation, we used 120 clinical samples from patients with PCR-confirmed SARS-CoV-2 infections, and displaying an S-gene target failure (SGTF) when using TaqPath COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. Our results showed that all the 120 samples harbored S Δ143-145 and N Δ31-33, which was further confirmed by Whole genome sequencing (WGS) of ten samples thereby validating our SYBR Green-based protocol. This protocol can be easily implemented to rapidly confirm the diagnosis of the Omicron BA.1 variant in COVID-19 patients and prevent its spread among populations, especially in countries with high prevalence of SGTF profile.\",\"PeriodicalId\":36528,\"journal\":{\"name\":\"Biology Methods and Protocols\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biology Methods and Protocols\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/biomethods/bpae020\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biology Methods and Protocols","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/biomethods/bpae020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
摘要
COVID-19 大流行正在全球不断蔓延,最近又在南非和博茨瓦纳发现了一种传播性极强的 Omicron SARS-CoV-2 变体(B.1.1.529)。快速鉴定这种变异体对于评估和遏制大流行至关重要。然而,变异体的鉴定主要使用昂贵且耗时的基因组测序技术。在本研究中,我们提出了另一种 RT-qPCR 方法,即使用低成本、快速的 SYBR Green 方法检测 Omicron BA.1 变异体。我们设计了特异性引物来确认作为该变异体特征的尖峰(S Δ143-145)和核壳(N Δ31-33)的缺失突变。为了进行评估,我们使用了 120 份经 PCR 鉴定为 SARS-CoV-2 感染者的临床样本,并在使用包括 ORF1ab、S 和 N 基因靶标的 TaqPath COVID-19 试剂盒(Thermo Fisher Scientific, Waltham, USA)时发现 S 基因靶标失败(SGTF)。我们的结果表明,所有 120 个样本都含有 S Δ143-145 和 N Δ31-33,其中 10 个样本的全基因组测序(WGS)进一步证实了这一点,从而验证了我们基于 SYBR Green 的方案。该方案易于实施,可快速确诊 COVID-19 患者中的 Omicron BA.1 变体,并防止其在人群中传播,尤其是在 SGTF 高发国家。
Detection of SARS-CoV-2 B.1.1.529 (omicron) variant by SYBR green‑based RT‑qPCR
The COVID-19 pandemic is unceasingly spreading across the globe, and recently a highly transmissible Omicron SARS-CoV-2 variant (B.1.1.529) has been discovered in South Africa and Botswana. Rapid identification of this variant is essential for pandemic assessment and containment. However, variant identification is mainly being performed using expensive and time-consuming genomic sequencing. In this study we propose an alternative RT-qPCR approach for the detection of the Omicron BA.1 variant using a low-cost and rapid SYBR Green method. We have designed specific primers to confirm the deletion mutations in the spike (S Δ143-145) and the nucleocapsid (N Δ31-33) which are characteristics of this variant. For the evaluation, we used 120 clinical samples from patients with PCR-confirmed SARS-CoV-2 infections, and displaying an S-gene target failure (SGTF) when using TaqPath COVID-19 kit (Thermo Fisher Scientific, Waltham, USA) that included the ORF1ab, S, and N gene targets. Our results showed that all the 120 samples harbored S Δ143-145 and N Δ31-33, which was further confirmed by Whole genome sequencing (WGS) of ten samples thereby validating our SYBR Green-based protocol. This protocol can be easily implemented to rapidly confirm the diagnosis of the Omicron BA.1 variant in COVID-19 patients and prevent its spread among populations, especially in countries with high prevalence of SGTF profile.